Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by BioTeckon Dec 14, 2021 10:46am
172 Views
Post# 34228731

RE:RE:NEXT NEWS

RE:RE:NEXT NEWSLOL another IR guy? When is spillup going to learn? Never obviously. How many is that now? Are we at 10 failed and costly attempts at IR now? What a joke, only thing left now for him to do is release news about another presentation and get that share price back to 1.20 where it belongs. All the IR in the world won't help this CEO.
MustangSalley wrote:

Well, a new VP of Investors Relations . Funny they don't mention name of healthcare company he worked for 23 years . Giving options away like candy 1.3 million dsu's.

I wonder if Chris knows that there is a shadow IR VP that has great influence in the name of Ray Matthews ? Why is Ray Matthews still around and how many dsu is he getting ?

Nothing on the 7 th patient ? 

Nothing but coal in the stockings for Sva investors .

MS



<< Previous
Bullboard Posts
Next >>